Announcements Trials
Browse Landscape

Phase

Phase 2 131Phase 1/2 40Phase 1 27Phase NA 21Phase 3 6Phase EARLY_PHASE1 3Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 21Neoplasms 8Prostatic Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Ovarian Neoplasms 4Endometrial Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Lung Neoplasms 3Head and Neck Neoplasms 3Glioma 3Depression 3Colorectal Neoplasms 3Brain Neoplasms 3Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Non-Muscle Invasive Bladder Neoplasms 2Neuroma, Acoustic 2Neurofibromatosis 2 2Myelodysplastic Syndromes 2Multiple Myeloma 2Medulloblastoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

ribociclib 1infigratinib 1Everolimus 1ABY-029 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Has results × Glioma × Clear all
NCT04424966 2025-10-24

Infigratinib in Recurrent High-Grade Glioma Patients

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Terminated
7 enrolled 18 charts
CNS

Glioblastoma, Glioma

NCT03834740 2025-05-30

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Completed
27 enrolled 17 charts
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT02901925 2024-12-13

ABY-029

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Completed
14 enrolled 10 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡